Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2021-06-23
2021-06-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pulse Oximeter Accuracy in Healthy Humans During Hypoxia
NCT06142019
Induced Hypoxia Study for Validation of SpO2 Accuracy
NCT00788983
Pulse Oximeter Hypoxia
NCT04562584
Accuracy of Pulse Oximeters With Profound Hypoxia
NCT05139693
Pulse Oximeter Test
NCT03569163
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Comparison of ANNE Limb Sensor pulse oximetry measurements to blood gas analysis
ANNE Limb Sensor
Pulse Oximeter
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ANNE Limb Sensor
Pulse Oximeter
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The subject is in good general health with no evidence of any medical problems
* The subject is fluent in both written and spoken English
* The subject has provided informed consent and is willing to comply with the study procedures.
Exclusion Criteria
* Diagnosis of asthma, sleep apnea, or use of CPAP
* Subject has diabetes
* Subject has a clotting disorder
* The subject has a hemoglobinopathy or history of anemia, per subject report or the first blood sample, that in the opinion of the investigator, would make them unsuitable for study participation
* The subject has any other serious systemic illness
* Th subject is a current smoker
* Any injury, deformity, or abnormality at the sensor sites that in the opinion of the investigators would interfere with the sensors working correctly
* The subject has a history of fainting or vasovagal response
* The subject has a history of sensitivity to local anesthesia
* The subject has a diagnosis of Raynaud's disease
* The subject has unacceptable collateral circulation based on exam by the investigator (Allen's test)
* The subject is pregnant, lactating, or trying to get pregnant
* The subject is unable or unwilling to provide informed consent, or is unable or unwilling to comply with study procedures
* The subject has any other condition, which in the opinion of the investigators would make them unsuitable for the study
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sibel Health Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hypoxia Research Laboratory Department of Anesthesia and Perioperative Care University of California, San Francisco
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SIBE01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.